Survival analysis is a branch of statistics that examines the expected duration until one or more events occur, such as death or failure. Traditionally applied in medical research and reliability ...
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial At a minimum ...
177Lu-DOTATATE Plus Radiosensitizing Capecitabine Versus Octreotide Long-Acting Release as First-Line Systemic Therapy in Advanced Grade 1 or 2 Gastroenteropancreatic Neuroendocrine Tumors: A ...
Five-year follow-up in a trial involving patients with previously untreated stage III or IV classic Hodgkin’s lymphoma showed long-term progression-free survival benefits with first-line therapy with ...
Time-of-day immunotherapy may represent a modifiable factor in cancer care, with earlier immune checkpoint inhibitor ...
We previously reported that olaparib led to significantly longer imaging-based progression-free survival than the physician’s choice of enzalutamide or abiraterone among men with metastatic castration ...
Investigators conducted a post-hoc analysis to determine the effect of race, socioeconomic factors, and clinicopathologic features on clinical outcomes in the ECOG-ACRIN EA1131 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results